Background Generalised myasthenia gravis is a chronic, unpredictable, and debilitating
autoimmune disease. New treatments for this disease are needed because conventional …

The orientation of mono(1,10-phenanthroline)copper(II), [Cu(phen)] 2+ , and the ternary
complexes with amino acids, [Cu(phen)X aa ] n+ , where X aa stands for an α-amino acid, has …

Aim: Prediabetes is an independent risk factor for future stroke. However, no effective treatment
has yet been established for the recurrence of stroke in patients with prediabetes. Here …

Introduction Despite differences in the pathogenesis and treatment of multiple sclerosis (MS)
and neuromyelitis optica spectrum disorders (NMOSD), it remains difficult to distinguish …

Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin
oligodendrocytes glycoprotein-antibody disease (MOGAD) are distinct autoimmune demyelinating …

Background Anti-aquaporin 4 (AQP4) antibody (AQP4-Ab) is involved in the pathogenesis
of neuromyelitis optica spectrum disorder (NMOSD). However, the mechanism involved in …

Local synthesis of antibodies and presence of oligoclonal bands in the cerebrospinal fluid (CSF)
are hallmarks of multiple sclerosis (MS). We investigated the frequency of antibodies …

Background Anti-myelin-associated-glycoprotein (MAG) neuropathy is a distal, predominantly
demyelinating, sensory or sensory-motor polyneuropathy most often developing in the …

Anti-aquaporin-4 antibody (NMO-IgG) is used as a diagnostic marker for neuromyelitis optica
(NMO). Although the mechanism of spinal cord lesions in NMO has been investigated, that …

Introduction Myelin-oligodendrocyte glycoprotein antibody (MOG)–associated disorder (MOGAD)
is a recently identified immune-mediated inflammatory disorder of the central nervous …